logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Marco Colleoni

irccs european institute of oncology
H指数:102
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Second ipsilateral locoregional recurrence in patients with hormone receptor-positive, HER2-negative breast cancer: a cohort study

激素受体阳性、HER2阴性乳腺癌患者中第二次同侧局部区域复发的队列研究

EClinicalMedicine
IF10
2026-08-010
PRE
Milano, Monica; Valenza, Carmine; Bianco, Nadia; Manacorda, Simona; Cavallone, Matteo; Matera, Letizia; Marsicano, Renato Maria; Battaiotto, Elena; Giachetti, Pier Paolo Maria Berton; Giordano, Edoardo; Etessami, Julian David; Trapani, Dario; Schena, Simone; Sangalli, Claudia; Fontana, Sabrina Kahler Ribeiro; Gandini, Sara; Veronesi, Paolo; Galimberti, Viviana; Colleoni, Marco; Curigliano, Giuseppe; Munzone, Elisabetta
Primary results from EL1SSAR, a prospective phase IIIb study of first-line atezolizumab plus nab-paclitaxel therapy for patients with PD-L1-positive advanced triple-negative breast cancer

EL1SSAR前瞻性IIIb期研究初步结果：PD-L1阳性晚期三阴性乳腺癌患者一线阿替利珠单抗联合白蛋白结合型紫杉醇治疗的疗效评估

The Breast
IF0
2026-06-080
OAAI
L. Gianni; S. Delaloge; E. Ciruelos; O. Trédan; C. Castañeda; M.H. Abreu; I. Paris; M. Colleoni; G. Scandurra; M. Kwiatkowski; N. Antone; V. Gregorc; P. Tagliaferri; S. Borštnar; I. Blancas; M. Raimondo; M. Alfie; C. Arce-Salinas; P.S. Madeira; Y.G. Lin
Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer

SOFT和TEXT III期试验在绝经前激素受体阳性早期乳腺癌中的最终结果

Annals of Oncology
IF65.4
2026-06-010
PRE
P.A. Francis; O. Pagani; G.F. Fleming; B.A. Walley; M. Colleoni; G. Rubovszky; C. Tondini; E.M. Ciruelos; H.L. Gomez; H.R. Bonnefoi; H.J. Burstein; C. Chini; F. Puglisi; S. Spazzapan; A. Bernardo; M.A. Climent; M. Bellet; T. Ruhstaller; B. Bermejo; S.K.L. Chia
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial

POSITIVE试验（女性内分泌敏感性乳腺癌中断治疗的妊娠结局与安全性）最新结果

Annals of Oncology
IF65.4
2026-05-280
PRE
Olivia Pagani; Samuel M. Niman; Monica Ruggeri; Fedro A. Peccatori; Hatem A. Azim; Marco Colleoni; Cristina Saura; Chikako Shimizu; Anna Barbro Sætersdal; Judith R. Kroep; Ellen Warner; Frédéric Amant; Audrey Mailliez; Halle C.F. Moore; Manuel Ruiz-Borrego; Janice M. Walshe; Virginia F. Borges; Andrea Gombos; Akemi Kataoka; Christine Rousset-Jablonski
A chemotherapy-free, pathological response-adapted strategy using trastuzumab–pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study☆

一种基于曲妥珠单抗–帕妥珠单抗和T-DM1的病理反应适应策略在HER2阳性早期乳腺癌中的应用：PHERGain-2研究☆

Annals of Oncology
IF65.4
2026-05-060
OA
L. Garrigós; M. Ruiz-Borrego; J.M. Pérez-García; A. Guerrero-Zotano; A. Cortés-Salgado; S. Kuemmel; M. Colleoni; C. Reboredo-Rendo; B. Bermejo; I. Blancas; J. Gavila; A. Fabi; C. Morales; A. Stradella; V. Carañana; E. Martínez-de Dueñas; C. Albacar; O. Ballesteros-Cidras; G. Martrat; S. Iacobucci
Metastasis-directed thermal ablation in patients with metastatic breast cancer and visceral oligoprogression or oligopersistence: a cohort study

针对伴有内脏寡进展或寡持续存在的转移性乳腺癌患者的转移灶导向热消融：一项队列研究

The Breast
IF0
2025-11-260
OAAI
Nadia Bianco; Carmine Valenza; Monica Milano; Roberta Multinu; Elena Battaiotto; Matteo Cavallone; Giulia Malvezzi; Dario Trapani; Paolo Della Vigna; Guido Bonomo; Gianluca M. Varano; Daniele Maiettini; Maria Giovanna Pitoni; Claudia Sangalli; Elisabetta Munzone; Giuseppe Curigliano; Marco A. Colleoni; Franco Orsi
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17)

帕博西利尼联合来曲唑与每周紫杉醇对比，两者均联合曲妥珠单抗联合帕妥珠单抗，作为人表皮生长因子受体2阳性激素受体阳性早期乳腺癌患者的术前辅助治疗：随机II期TOUCH试验（IBCSG 55-17）的主要结果

Annals of Oncology
IF65.4
2025-10-160
PRE
L. Malorni; S. Tyekucheva; A. Gombos; U. Hasler-Strub; C. Zamagni; C. Chakiba-Brugère; M. Colleoni; A. Mueller; A.M. Minisini; D. Taylor; J.P. Salmon; E. Gallerani; A. Cariello; A. Fontana; H. Roschitzki-Voser; R. Kammler; B. Ruepp; S. Loi; G. Viale; M.M. Regan; E. Brain; L. Biganzoli
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancer

肿瘤特异性主要组织相容性-II表达预测三阴性乳腺癌中阿替利珠单抗联合化疗的病理完全缓解

npj Breast Cancer
IF7.6
2025-09-290
OAAI
Justin M. Balko; Luca Licata; Xiao Qian Wang; Matteo Dugo; Chiun-Sheng Huang; Daniel Egle; Begoña Bermejo; Claudio Zamagni; Marc Thill; Antonio Anton; Stefania Russo; Elena Sevillano; Eva Maria Ciruelos; Richard Greil; Vladimir Semiglazov; Marco Colleoni; Catherine M. Kelly; Gabriella Mariani; Lucia Del Mastro; Stefania Zambelli; Giulia Viale; Maurizio Callari; Giuseppe Viale; Lajos Pusztai; Luca Gianni; H. Raza Ali; Giampaolo Bianchini
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT

TEXT和SOFT研究中激素受体阳性早期乳腺癌女性患者报告抑郁的预后价值

Cancer
IF5.1
2025-09-230
PRE
Karin Ribi PhD; Bernard F. Cole PhD; Gini F. Fleming MD; Barbara A. Walley MD; Prudence A. Francis MD; Ehtesham Abdi MD; Harold J. Burstein MD, PhD; Kit L. Cheng MD; Stephen K. L. Chia MD, FRCP; Shaker R. Dakhil MD; Nancy E. Davidson MD; Stephen A. Della-Fiorentina MD; Ashley E. Frith MD; Ellis Levine MD; Sasha Lupichuk MD; Kathleen Pritchard MD; Muhammad Salim MD; Vered Stearns MD; Josephine Stewart MD; Vicente Valero MD; Andre van der Westhuizen MD; Olivia Pagani MD; Sherene Loi MD, PhD; Marco Colleoni MD; Richard D. Gelber PhD; Aron Goldhirsch MD; Alan S. Coates MD; Meredith M. Regan ScD; Jürg Bernhard PhD
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

勘误：“Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

The Breast
IF0
2025-09-220
PREAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group

浸润性小叶癌：小叶性乳腺癌研究小组的策略与展望

Cancer Treatment Reviews
IF10.5
2025-08-070
OAAI
Giovanni Corso; Sherry Shen; Carmen Criscitiello; Rita Mukhtar; Lauren Gamble; Elena Guerini Rocco; Filippo Pesapane; Luca Nicosia; Komal Jhaveri; Beatrice Taurelli Salimbeni; Giulia Massari; Eleonora Meduri; Alessandra Margherita De Scalzi; Alberto Concardi; Francesca Magnoni; Anita Mamtani; Fresia Pareja; Maria Cristina Leonardi; Virgilio Sacchini; Giorgio Bogani; Carlo La Vecchia; Daniele Presti; Marco Angelo Colleoni; Paolo Veronesi; Mark E. Robson
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中，预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

breast
IF0
2025-07-260
OAAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
IMpassion132 double-blind randomised phase III trial of chemotherapy with or without atezolizumab for early relapsing unresectable locally advanced or metastatic triple-negative breast cancer

IMpassion132化疗加或不加阿特珠单抗治疗早期复发性不可切除的局部晚期或转移性三阴性乳腺癌的双盲随机III期试验

ANNALS OF ONCOLOGY
IF65.4
2024-07-014
OAAI
Dent, R.; Andre, F.; Goncalves, A.; Martin, M.; Schmid, P.; Schuetz, F.; Kuemmel, S.; Swain, S. M.; Bilici, A.; Loirat, D.; Valencia, R. Villalobos; Im, S. -A; Park, Y. H.; De Laurentis, M.; Colleoni, M.; Guarneri, V.; Bianchini, G.; Li, H.; Machackova, Z. Kirchmayer; Mouta, J.; Deurloo, R.; Gan, X.; Fan, M.; Mani, A.; Swat, A.; Cortes, J.
PARSIFAL-LONG: Extended follow-up of hormone receptor-positive/ HER2-negative advanced breast cancer patients treated with fulvestrant and palbociclib vs. letrozole and palbociclib in the PARSIFAL study
CANCER RESEARCH
IF16.6
2024-05-022
PRE
Llombart-Cussac, Antonio; Perez-Garcia, Jose Manuel; Bellet-Ezquerra, Meritxell; Dalenc, Florence; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Gavila, Joaquin; Schmid, Peter; Zamora, Pilar; Wheatley, Duncan; Martinez-de Duenas, Eduardo; Amillano, Kepa; Anton, Antonio; Cottu, Paul; Vinas, Gemma; Petit, Thierry; Tesarova, Petra; Cueva, Juan; Colleoni, Marco; del Prado, Maria Purificacion Martinez; Andres, Raquel; Cabo, Marta Diaz; Victorino, Susana; Sampayo-Cordero, Miguel; Cortes, Javier

研究方向

暂未获取到该数据
A
Aron Goldhirsch
H 指数:122论文数:1,029被引数:7.3万
G
Giuseppe Viale
H 指数:157论文数:1,264被引数:11.3万
P
Paolo Veronesi
H 指数:91论文数:770被引数:3.2万
R
Richard D. Gelber
H 指数:133论文数:594被引数:9.0万
A
Alberto Luini
H 指数:111论文数:643被引数:5.1万
N
Nicole Rotmensz
H 指数:76论文数:461被引数:1.7万
E
Emilia Montagna
H 指数:36论文数:106被引数:5,015
M
Mattia Intra
H 指数:67论文数:229被引数:1.8万
A
Alan S. Coates
H 指数:97论文数:418被引数:5.2万
M
Meredith M. Regan
H 指数:95论文数:676被引数:4.2万